Summary
A 46-year-old defense contractor employee was granted a security clearance despite concerns under Guideline H (Drug Involvement). The applicant tested positive for the marijuana metabolite THC on October 17, 2000, following an isolated incident of use at a party. This positive test led to allegations regarding his drug involvement.
In response to these concerns, the applicant obtained a substance abuse evaluation on November 1, 2000, and completed an eight-hour alcohol and drug education program. A professional evaluator assessed him as a low risk for chemical dependency.
The judge determined that the applicant had mitigated the security concerns related to his drug use. This decision was based on the successful completion of the drug education program, the low-risk assessment for chemical dependency, and the finding that the drug use was an isolated incident. The judge also found the applicant's assertion of future abstinence credible, leading to the granting of the security clearance.
Why the Applicant Prevailed
- The applicant successfully completed a drug education program after testing positive for THC.
- He was assessed as a low risk for chemical dependency by a professional evaluator.
- The judge found the applicant's drug use to be an isolated incident and credible in his assertion of future abstinence.
Conditions Referenced
- H.1raisedAny Drug Abuse
- H.1appliedThe Drug Involvement Was Not Recent
- H.2appliedThe Drug Involvement Was an Isolated or Aberrational Event
- H.3appliedA Demonstrated Intent Not to Abuse Any Drugs in the Future
Key Rule Quoted
“The sole purpose of a security clearance decision is to decide if it is clearly consistent with the national interest to grant or continue a security clearance for an applicant.”
Procedural Posture
- SOR issuedSep 17, 2003
- Answer filedOct 27, 2003
- Hearing heldFeb 5, 2004
- Decision dateApr 16, 2004
Cite For
- Mitigation of Drug Use Under Guideline H
- Impact of Isolated Drug Incidents on Security Clearance Decisions
- Importance of Professional Evaluations in Drug-related Clearance Cases